Skip to main content
Earnings Labs
Haemonetics Corporation logo

Haemonetics Corporation (HAE)

NYSE·Healthcare·Medical - Devices

$118.97

-0.83%

Mkt Cap $5.39B

Analyst Ratings

Buy

15

Hold

4

Sell

0

Price Target (24 analysts)

$108.60

Range $85.00 – $125.00

Implied Upside

-8.7%

Consensus $108.60 vs current $118.97